Pfizer (NYSE:PFE) announced robust sales for the antifungal drug Cresemba in partnership with Basilea Pharmaceutica Ltd, ...

Bank of America maintained its buy rating on Nvidia's stock, which Arya said is a top sector pick with a price target of $180. While the stock has been in recovery mode and is closing in on its record ...

A CRN analysis found that Nvidia finished the first quarter with more than double the revenue of what Intel and AMD earned ...

Mark A Stevens, Board Member at NVIDIA NVDA, disclosed an insider sell on June 4, according to a recent SEC filing. What Happened: Stevens's recent Form 4 filing with the U.S. Securities and Exchange ...

Broadcom (AVGO) has been a major player in the semiconductor space, especially as the AI race heats up between tech giants.

Nebius sees hypergrowth with ARR up 177% and revenue surging by 385%. Backed by Nvidia, NBIS stock is a top AI investment for ...

Shares of the data-analysis software company closed at a record for a third consecutive day Tuesday, pushing their gain for ...

The Hartford Large Cap Growth has emerged as a leading large-cap growth fund with strong GARP metrics, big tech exposure, and ...

Illumina provides sequencing- and array-based solutions for genetic and genomic analysis. It has roughly 80% share in its ...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.

It's important to note that this isn't the first time Nvidia has claimed the title of the world's most valuable company. In ...

Nvidia and its partners were the only entrants that submitted data about training that large model, and the data showed that ...